# Dexamethasone Administered Via the Epidural Catheter as an Adjunct in Patients Undergoing Cesarean Delivery

> **NCT03877549** · PHASE4 · WITHDRAWN · sponsor: **Henry Ford Health System**

## Conditions studied

- Post Operative Pain

## Interventions

- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT03877549
- **Lead sponsor:** Henry Ford Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-05-24
- **Primary completion:** 2022-06-15
- **Final completion:** 2022-06-15
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PI left Henry Ford Health before completion.
- **Last updated:** 2023-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03877549

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03877549, "Dexamethasone Administered Via the Epidural Catheter as an Adjunct in Patients Undergoing Cesarean Delivery". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT03877549. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*